Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Aromatase inhibitors and arthralgias: a new frontier in symptom management for breast cancer survivors.

Literature DB >> 17761968

Aromatase inhibitors and arthralgias: a new frontier in symptom management for breast cancer survivors.

Harold J Burstein, Eric P Winer.

Abstract

Entities: Disease

Mesh：

Substances：
Aromatase Inhibitors

Year: 2007 PMID： 17761968 DOI： 10.1200/JCO.2007.11.9529

Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544

Keyword Cloud
Cited

× No keyword cloud information.

20 in total

1. The CIRAS study: a case control study to define the clinical, immunologic, and radiographic features of aromatase inhibitor-induced musculoskeletal symptoms.

Authors: Victoria K Shanmugam; James McCloskey; Beth Elston; Sandra J Allison; Jennifer Eng-Wong
Journal: Breast Cancer Res Treat Date: 2011-11-11 Impact factor: 4.872

2. Undesirable effects related to oral antineoplastic drugs: comparison between patients' internet narratives and a national pharmacovigilance database.

Authors: Arnaud Pages; Emmanuelle Bondon-Guitton; Jean Louis Montastruc; Haleh Bagheri
Journal: Drug Saf Date: 2014-08 Impact factor: 5.606

Review 3. American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.

Authors: Harold J Burstein; Ann Alexis Prestrud; Jerome Seidenfeld; Holly Anderson; Thomas A Buchholz; Nancy E Davidson; Karen E Gelmon; Sharon H Giordano; Clifford A Hudis; Jennifer Malin; Eleftherios P Mamounas; Diana Rowden; Alexander J Solky; Maryfran R Sowers; Vered Stearns; Eric P Winer; Mark R Somerfield; Jennifer J Griggs
Journal: J Clin Oncol Date: 2010-07-12 Impact factor: 44.544

4. Randomized phase II placebo-controlled study to evaluate the efficacy of topical pure emu oil for joint pain related to adjuvant aromatase inhibitor use in postmenopausal women with early breast cancer: JUST (Joints Under Study).

Authors: Arlene Chan; R De Boer; A Gan; P Willsher; R Martin; Y Zissiadis; K Miller; A Bauwens; D Hastrich
Journal: Support Care Cancer Date: 2017-07-09 Impact factor: 3.603

5. A prospective pilot study investigating the musculoskeletal pain in postmenopausal breast cancer patients receiving aromatase inhibitor therapy.

Authors: A Robidoux; E Rich; N J Bureau; S Mader; D Laperrière; M Bail; N Tremblay; M Patenaude; J Turgeon
Journal: Curr Oncol Date: 2011-12 Impact factor: 3.677

Aromatase inhibitors and arthralgias: a new frontier in symptom management for breast cancer survivors.

1. The CIRAS study: a case control study to define the clinical, immunologic, and radiographic features of aromatase inhibitor-induced musculoskeletal symptoms.

2. Undesirable effects related to oral antineoplastic drugs: comparison between patients' internet narratives and a national pharmacovigilance database.

Review 3. American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.

4. Randomized phase II placebo-controlled study to evaluate the efficacy of topical pure emu oil for joint pain related to adjuvant aromatase inhibitor use in postmenopausal women with early breast cancer: JUST (Joints Under Study).

5. A prospective pilot study investigating the musculoskeletal pain in postmenopausal breast cancer patients receiving aromatase inhibitor therapy.

6. Online discussion of drug side effects and discontinuation among breast cancer survivors.

7. A randomised trial of electro-acupuncture for arthralgia related to aromatase inhibitor use.

8. Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors.

Review 9. Update on the use of aromatase inhibitors in early-stage breast cancer.

10. Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case-control study.